Physician profile
Michael Thomas
NPI 1164158929
$4,801.85
in general payments reported to CMS, 2019-2025
10 companies · $2,196 in 2025
The $2,196 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $836 · 2024: $1,770 · 2025: $2,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,407 · Education: $245 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,406.87 |
| Education | $244.98 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,968.93 | 2023-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $1,283.66 | 2023-2025 | Lumryz |
| Harmony Biosciences LLC | $594.11 | 2023-2025 | Wakix |
| Axsome Therapeutics, INC. | $427.68 | 2023-2025 | Sunosi |
| Azurity Pharmaceuticals, INC. | $278.51 | 2023-2025 | Horizant, Horizant |
| Lilly USA, LLC | $122.36 | 2025 | Zepbound |
| Fisher & Paykel Healthcare INC | $55.85 | 2024 | Fisher & Paykel Healthcare |
| Idorsia Pharmaceuticals US INC | $26.34 | 2024 | Quviviq |
| Zoll Respicardia, INC. | $23.09 | 2025 | Remede System |
| Inspire Medical Systems, INC. | $21.32 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.